| Year |
Citation |
Score |
| 2020 |
van der Merwe NJ, Karayiorgou M, Ehlers R, Roos JL. Family history identifies sporadic schizoaffective disorder as a subtype for genetic studies. The South African Journal of Psychiatry : Sajp : the Journal of the Society of Psychiatrists of South Africa. 26: 1393. PMID 32391182 DOI: 10.4102/Sajpsychiatry.V26I0.1393 |
0.438 |
|
| 2019 |
Flex E, Martinelli S, Van Dijck A, Ciolfi A, Cecchetti S, Coluzzi E, Pannone L, Andreoli C, Radio FC, Pizzi S, Carpentieri G, Bruselles A, Catanzaro G, Pedace L, Miele E, ... ... Karayiorgou M, et al. Aberrant Function of the C-Terminal Tail of HIST1H1E Accelerates Cellular Senescence and Causes Premature Aging. American Journal of Human Genetics. PMID 31447100 DOI: 10.1016/J.Ajhg.2019.07.007 |
0.302 |
|
| 2018 |
van der Merwe N, Karayiorgou M, Ehlers R, Roos J. S189. CARVING A MORE SPECIFIC SUBTYPE OF SCHIZOPHRENIA FOR GENETIC STUDIES: SPORADIC SCHIZOAFFECTIVE BIPOLAR TYPE Schizophrenia Bulletin. 44: S399-S399. DOI: 10.1093/Schbul/Sby018.976 |
0.466 |
|
| 2017 |
Diamantopoulou A, Sun Z, Mukai J, Xu B, Fenelon K, Karayiorgou M, Gogos JA. Loss-of-function mutation in Mirta22/Emc10 rescues specific schizophrenia-related phenotypes in a mouse model of the 22q11.2 deletion. Proceedings of the National Academy of Sciences of the United States of America. PMID 28696314 DOI: 10.1073/Pnas.1615719114 |
0.836 |
|
| 2017 |
Malherbe PJ, Karayiorgou M, Ehlers R, Roos JL. Increased risk of suicide in schizophrenia patients with linkage to chromosome 13q. Psychiatry Research. 251: 34-35. PMID 28189075 DOI: 10.1016/J.Psychres.2017.02.008 |
0.412 |
|
| 2017 |
Qi Y, Zhang XJ, Renier N, Wu Z, Atkin T, Sun Z, Ozair MZ, Tchieu J, Zimmer B, Fattahi F, Ganat Y, Azevedo R, Zeltner N, Brivanlou AH, Karayiorgou M, et al. Combined small-molecule inhibition accelerates the derivation of functional cortical neurons from human pluripotent stem cells. Nature Biotechnology. PMID 28112759 DOI: 10.1038/Nbt.3777 |
0.766 |
|
| 2016 |
Wesseling H, Xu B, Want EJ, Holmes E, Guest PC, Karayiorgou M, Gogos JA, Bahn S. System-based proteomic and metabonomic analysis of the Df(16)A(+/-) mouse identifies potential miR-185 targets and molecular pathway alterations. Molecular Psychiatry. PMID 27001617 DOI: 10.1038/Mp.2016.27 |
0.747 |
|
| 2016 |
Takata A, Ionita-Laza I, Gogos JA, Xu B, Karayiorgou M. De Novo Synonymous Mutations in Regulatory Elements Contribute to the Genetic Etiology of Autism and Schizophrenia. Neuron. 89: 940-7. PMID 26938441 DOI: 10.1016/J.Neuron.2016.02.024 |
0.733 |
|
| 2015 |
Barr I, Weitz SH, Atkin T, Hsu P, Karayiorgou M, Gogos JA, Weiss S, Guo F. Cobalt(III) Protoporphyrin Activates the DGCR8 Protein and Can Compensate microRNA Processing Deficiency. Chemistry & Biology. 22: 793-802. PMID 26091172 DOI: 10.1016/J.Chembiol.2015.05.015 |
0.769 |
|
| 2015 |
Levy RJ, Kvajo M, Li Y, Tsvetkov E, Dong W, Yoshikawa Y, Kataoka T, Bolshakov VY, Karayiorgou M, Gogos JA. Deletion of Rapgef6, a candidate schizophrenia susceptibility gene, disrupts amygdala function in mice. Translational Psychiatry. 5: e577. PMID 26057047 DOI: 10.1038/Tp.2015.75 |
0.78 |
|
| 2015 |
Mukai J, Tamura M, Fénelon K, Rosen AM, Spellman TJ, Kang R, MacDermott AB, Karayiorgou M, Gordon JA, Gogos JA. Molecular substrates of altered axonal growth and brain connectivity in a mouse model of schizophrenia. Neuron. 86: 680-95. PMID 25913858 DOI: 10.1016/J.Neuron.2015.04.003 |
0.812 |
|
| 2015 |
Hsu PK, Xu B, Mukai J, Karayiorgou M, Gogos JA. The BDNF Val66Met variant affects gene expression through miR-146b. Neurobiology of Disease. 77: 228-37. PMID 25771167 DOI: 10.1016/J.Nbd.2015.03.004 |
0.787 |
|
| 2015 |
Malherbe PJ, Roos JL, Ehlers R, Karayiorgou M, Roos JL. Phenotypic features of patients with schizophrenia carrying de novo gene mutations: a pilot study. Psychiatry Research. 225: 108-14. PMID 25467704 DOI: 10.1016/J.Psychres.2014.10.024 |
0.448 |
|
| 2014 |
Karayannis T, Au E, Patel JC, Kruglikov I, Markx S, Delorme R, Héron D, Salomon D, Glessner J, Restituito S, Gordon A, Rodriguez-Murillo L, Roy NC, Gogos JA, Rudy B, ... ... Karayiorgou M, et al. Cntnap4 differentially contributes to GABAergic and dopaminergic synaptic transmission. Nature. 511: 236-40. PMID 24870235 DOI: 10.1038/Nature13248 |
0.733 |
|
| 2014 |
Takata A, Xu B, Ionita-Laza I, Roos JL, Gogos JA, Karayiorgou M. Loss-of-function variants in schizophrenia risk and SETD1A as a candidate susceptibility gene. Neuron. 82: 773-80. PMID 24853937 DOI: 10.1016/J.Neuron.2014.04.043 |
0.779 |
|
| 2014 |
Ellegood J, Markx S, Lerch JP, Steadman PE, Genç C, Provenzano F, Kushner SA, Henkelman RM, Karayiorgou M, Gogos JA. A highly specific pattern of volumetric brain changes due to 22q11.2 deletions in both mice and humans. Molecular Psychiatry. 19: 6. PMID 24362540 DOI: 10.1038/Mp.2013.179 |
0.714 |
|
| 2014 |
Ionita-Laza I, Xu B, Makarov V, Buxbaum JD, Roos JL, Gogos JA, Karayiorgou M. Scan statistic-based analysis of exome sequencing data identifies FAN1 at 15q13.3 as a susceptibility gene for schizophrenia and autism. Proceedings of the National Academy of Sciences of the United States of America. 111: 343-8. PMID 24344280 DOI: 10.1073/Pnas.1309475110 |
0.753 |
|
| 2014 |
Rodriguez-Murillo L, Xu B, Roos JL, Abecasis GR, Gogos JA, Karayiorgou M. Fine mapping on chromosome 13q32-34 and brain expression analysis implicates MYO16 in schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 934-43. PMID 24141571 DOI: 10.1038/Npp.2013.293 |
0.765 |
|
| 2014 |
Ellegood J, Markx S, Lerch JP, Steadman PE, Genç C, Provenzano F, Kushner SA, Henkelman RM, Karayiorgou M, Gogos JA. Neuroanatomical phenotypes in a mouse model of the 22q11.2 microdeletion. Molecular Psychiatry. 19: 99-107. PMID 23999526 DOI: 10.1038/Mp.2013.112 |
0.761 |
|
| 2014 |
Malherbe PJ, Roos JL, Roos JL, Karayiorgou M, Ehlers R. Poster #T152 PHENOTYPIC FEATURES OF PATIENTS WITH SCHIZOPHRENIA CARRYING DE NOVO GENE MUTATIONS Schizophrenia Research. 153: S344. DOI: 10.1016/S0920-9964(14)70969-7 |
0.426 |
|
| 2013 |
Fénelon K, Xu B, Lai CS, Mukai J, Markx S, Stark KL, Hsu PK, Gan WB, Fischbach GD, MacDermott AB, Karayiorgou M, Gogos JA. The pattern of cortical dysfunction in a mouse model of a schizophrenia-related microdeletion. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 14825-39. PMID 24027283 DOI: 10.1523/Jneurosci.1611-13.2013 |
0.814 |
|
| 2013 |
Lepagnol-Bestel AM, Kvajo M, Karayiorgou M, Simonneau M, Gogos JA. A Disc1 mutation differentially affects neurites and spines in hippocampal and cortical neurons. Molecular and Cellular Neurosciences. 54: 84-92. PMID 23396153 DOI: 10.1016/J.Mcn.2013.01.006 |
0.736 |
|
| 2013 |
Xu B, Hsu PK, Stark KL, Karayiorgou M, Gogos JA. Derepression of a neuronal inhibitor due to miRNA dysregulation in a schizophrenia-related microdeletion. Cell. 152: 262-75. PMID 23332760 DOI: 10.1016/J.Cell.2012.11.052 |
0.798 |
|
| 2013 |
Huey ED, Nagy PL, Rodriguez-Murillo L, Manoochehri M, Goldman J, Lieberman J, Karayiorgou M, Mayeux R. C9ORF72 repeat expansions not detected in a group of patients with schizophrenia. Neurobiology of Aging. 34: 1309.e9-10. PMID 23036583 DOI: 10.1016/J.Neurobiolaging.2012.08.011 |
0.436 |
|
| 2012 |
Gilman SR, Chang J, Xu B, Bawa TS, Gogos JA, Karayiorgou M, Vitkup D. Diverse types of genetic variation converge on functional gene networks involved in schizophrenia. Nature Neuroscience. 15: 1723-8. PMID 23143521 DOI: 10.1038/Nn.3261 |
0.774 |
|
| 2012 |
Xu B, Ionita-Laza I, Roos JL, Boone B, Woodrick S, Sun Y, Levy S, Gogos JA, Karayiorgou M. De novo gene mutations highlight patterns of genetic and neural complexity in schizophrenia. Nature Genetics. 44: 1365-9. PMID 23042115 DOI: 10.1038/Ng.2446 |
0.767 |
|
| 2012 |
Karayiorgou M, Flint J, Gogos JA, Malenka RC. The best of times, the worst of times for psychiatric disease. Nature Neuroscience. 15: 811-2. PMID 22627793 DOI: 10.1038/Nn.3115 |
0.675 |
|
| 2012 |
Behan AT, Hryniewiecka M, O'Tuathaigh CM, Kinsella A, Cannon M, Karayiorgou M, Gogos JA, Waddington JL, Cotter DR. Chronic adolescent exposure to delta-9-tetrahydrocannabinol in COMT mutant mice: impact on indices of dopaminergic, endocannabinoid and GABAergic pathways. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 1773-83. PMID 22434221 DOI: 10.1038/Npp.2012.24 |
0.742 |
|
| 2012 |
Xu B, Hsu PK, Karayiorgou M, Gogos JA. MicroRNA dysregulation in neuropsychiatric disorders and cognitive dysfunction. Neurobiology of Disease. 46: 291-301. PMID 22406400 DOI: 10.1016/J.Nbd.2012.02.016 |
0.76 |
|
| 2012 |
Levy RJ, Xu B, Gogos JA, Karayiorgou M. Copy number variation and psychiatric disease risk. Methods in Molecular Biology (Clifton, N.J.). 838: 97-113. PMID 22228008 DOI: 10.1007/978-1-61779-507-7_4 |
0.757 |
|
| 2012 |
Desbonnet L, Tighe O, Karayiorgou M, Gogos JA, Waddington JL, O'Tuathaigh CM. Physiological and behavioural responsivity to stress and anxiogenic stimuli in COMT-deficient mice. Behavioural Brain Research. 228: 351-8. PMID 22192380 DOI: 10.1016/J.Bbr.2011.12.014 |
0.696 |
|
| 2012 |
O'Tuathaigh CM, Clarke G, Walsh J, Desbonnet L, Petit E, O'Leary C, Tighe O, Clarke N, Karayiorgou M, Gogos JA, Dinan TG, Cryan JF, Waddington JL. Genetic vs. pharmacological inactivation of COMT influences cannabinoid-induced expression of schizophrenia-related phenotypes. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 15: 1331-42. PMID 22074909 DOI: 10.1017/S1461145711001581 |
0.753 |
|
| 2012 |
Rodriguez-Murillo L, Gogos JA, Karayiorgou M. The genetic architecture of schizophrenia: new mutations and emerging paradigms. Annual Review of Medicine. 63: 63-80. PMID 22034867 DOI: 10.1016/S0920-9964(12)70096-8 |
0.768 |
|
| 2012 |
Schendzielorz N, Männistö PT, Karayiorgou M, Gogos JA, Raasmaja A. A transient inhibition and permanent lack of catechol-O-methyltransferase have minor effects on feeding pattern of female rodents. Basic & Clinical Pharmacology & Toxicology. 110: 307-13. PMID 21851556 DOI: 10.1111/J.1742-7843.2011.00783.X |
0.71 |
|
| 2011 |
Malhotra D, McCarthy S, Michaelson JJ, Vacic V, Burdick KE, Yoon S, Cichon S, Corvin A, Gary S, Gershon ES, Gill M, Karayiorgou M, Kelsoe JR, Krastoshevsky O, Krause V, et al. High frequencies of de novo CNVs in bipolar disorder and schizophrenia. Neuron. 72: 951-63. PMID 22196331 DOI: 10.1016/J.Neuron.2011.11.007 |
0.404 |
|
| 2011 |
Kvajo M, McKellar H, Drew LJ, Lepagnol-Bestel AM, Xiao L, Levy RJ, Blazeski R, Arguello PA, Lacefield CO, Mason CA, Simonneau M, O'Donnell JM, MacDermott AB, Karayiorgou M, Gogos JA. Altered axonal targeting and short-term plasticity in the hippocampus of Disc1 mutant mice. Proceedings of the National Academy of Sciences of the United States of America. 108: E1349-58. PMID 22049344 DOI: 10.1073/pnas.1114113108 |
0.799 |
|
| 2011 |
Marder SR, Roth B, Sullivan PF, Scolnick EM, Nestler EJ, Geyer MA, Welnberger DR, Karayiorgou M, Guidotti A, Gingrich J, Akbarian S, Buchanan RW, Lieberman JA, Conn PJ, Haggarty SJ, et al. Advancing drug discovery for schizophrenia. Annals of the New York Academy of Sciences. 1236: 30-43. PMID 22032400 DOI: 10.1111/J.1749-6632.2011.06216.X |
0.442 |
|
| 2011 |
Xu B, Roos JL, Dexheimer P, Boone B, Plummer B, Levy S, Gogos JA, Karayiorgou M. Exome sequencing supports a de novo mutational paradigm for schizophrenia. Nature Genetics. 43: 864-8. PMID 21822266 DOI: 10.1038/Ng.902 |
0.765 |
|
| 2011 |
Drew LJ, Stark KL, Fénelon K, Karayiorgou M, Macdermott AB, Gogos JA. Evidence for altered hippocampal function in a mouse model of the human 22q11.2 microdeletion. Molecular and Cellular Neurosciences. 47: 293-305. PMID 21635953 DOI: 10.1016/J.Mcn.2011.05.008 |
0.819 |
|
| 2011 |
Fénelon K, Mukai J, Xu B, Hsu PK, Drew LJ, Karayiorgou M, Fischbach GD, Macdermott AB, Gogos JA. Deficiency of Dgcr8, a gene disrupted by the 22q11.2 microdeletion, results in altered short-term plasticity in the prefrontal cortex. Proceedings of the National Academy of Sciences of the United States of America. 108: 4447-52. PMID 21368174 DOI: 10.1073/Pnas.1101219108 |
0.816 |
|
| 2011 |
Vacic V, McCarthy S, Malhotra D, Murray F, Chou HH, Peoples A, Makarov V, Yoon S, Bhandari A, Corominas R, Iakoucheva LM, Krastoshevsky O, Krause V, Larach-Walters V, Welsh DK, ... ... Karayiorgou M, et al. Duplications of the neuropeptide receptor gene VIPR2 confer significant risk for schizophrenia. Nature. 471: 499-503. PMID 21346763 DOI: 10.1038/Nature09884 |
0.489 |
|
| 2011 |
Drew LJ, Crabtree GW, Markx S, Stark KL, Chaverneff F, Xu B, Mukai J, Fenelon K, Hsu PK, Gogos JA, Karayiorgou M. The 22q11.2 microdeletion: fifteen years of insights into the genetic and neural complexity of psychiatric disorders. International Journal of Developmental Neuroscience : the Official Journal of the International Society For Developmental Neuroscience. 29: 259-81. PMID 20920576 DOI: 10.1016/J.Ijdevneu.2010.09.007 |
0.821 |
|
| 2011 |
Vacic V, McCarthy S, Malhotra D, Murray F, Chou HH, Peoples A, Makarov V, Yoon S, Bhandari A, Corominas R, Iakoucheva LM, Krastoshevsky O, Krause V, Larach-Walters V, Welsh DK, ... ... Karayiorgou M, et al. Duplications of the neuropeptide receptor gene VIPR2 confer significant risk for schizophrenia (Nature (2011) 471 (499-501)) Nature. 474: 114. DOI: 10.1038/Nature10088 |
0.432 |
|
| 2010 |
O'Tuathaigh CM, Hryniewiecka M, Behan A, Tighe O, Coughlan C, Desbonnet L, Cannon M, Karayiorgou M, Gogos JA, Cotter DR, Waddington JL. Chronic adolescent exposure to Δ-9-tetrahydrocannabinol in COMT mutant mice: impact on psychosis-related and other phenotypes. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 2262-73. PMID 20631688 DOI: 10.1038/Npp.2010.100 |
0.694 |
|
| 2010 |
Käenmäki M, Tammimäki A, Myöhänen T, Pakarinen K, Amberg C, Karayiorgou M, Gogos JA, Männistö PT. Quantitative role of COMT in dopamine clearance in the prefrontal cortex of freely moving mice. Journal of Neurochemistry. 114: 1745-55. PMID 20626558 DOI: 10.1111/J.1471-4159.2010.06889.X |
0.705 |
|
| 2010 |
Walsh J, Tighe O, Lai D, Harvey R, Karayiorgou M, Gogos JA, Waddington JL, O'Tuathaigh CM. Disruption of thermal nociceptive behaviour in mice mutant for the schizophrenia-associated genes NRG1, COMT and DISC1. Brain Research. 1348: 114-9. PMID 20561508 DOI: 10.1016/J.Brainres.2010.06.027 |
0.735 |
|
| 2010 |
Karayiorgou M, Simon TJ, Gogos JA. 22q11.2 microdeletions: linking DNA structural variation to brain dysfunction and schizophrenia. Nature Reviews. Neuroscience. 11: 402-16. PMID 20485365 DOI: 10.1038/Nrn2841 |
0.768 |
|
| 2010 |
Xu B, Karayiorgou M, Gogos JA. MicroRNAs in psychiatric and neurodevelopmental disorders. Brain Research. 1338: 78-88. PMID 20388499 DOI: 10.1016/J.Brainres.2010.03.109 |
0.728 |
|
| 2010 |
Sigurdsson T, Stark KL, Karayiorgou M, Gogos JA, Gordon JA. Impaired hippocampal-prefrontal synchrony in a genetic mouse model of schizophrenia. Nature. 464: 763-7. PMID 20360742 DOI: 10.1038/Nature08855 |
0.785 |
|
| 2010 |
Arguello PA, Markx S, Gogos JA, Karayiorgou M. Development of animal models for schizophrenia. Disease Models & Mechanisms. 3: 22-6. PMID 20075378 DOI: 10.1242/Dmm.003996 |
0.793 |
|
| 2010 |
O'Tuathaigh C, Walsh J, Tighe O, Karayiorgou M, Gogos J, Harvey R, Lai D, Waddington J. P.3.b.010 Examination of nociceptive behaviour and stress reactivity in susceptibility gene mutant models of schizophrenia European Neuropsychopharmacology. 20: S457-S458. DOI: 10.1016/S0924-977X(10)70670-2 |
0.411 |
|
| 2010 |
O'Tuathaigh CM, Hryniewiecka M, Behan A, Tighe O, Cannon M, Karayiorgou M, Gogos JA, Cotter DR, Waddington JL. Differential Effects Of Chronic Adolescent Vs. Adult Thc Exposure In Comt Knockout Mice On Phenotypes Relevant To Psychosis Schizophrenia Research. 117: 507-508. DOI: 10.1016/J.Schres.2010.02.969 |
0.308 |
|
| 2010 |
Karayiorgou M, Gogos JA. COPY NUMBER VARIATION IN SCHIZOPHRENIA: MODELING 22Q11 Schizophrenia Research. 117: 108-109. DOI: 10.1016/J.Schres.2010.02.020 |
0.761 |
|
| 2009 |
Käenmäki M, Tammimäki A, Garcia-Horsman JA, Myöhänen T, Schendzielorz N, Karayiorgou M, Gogos JA, Männistö PT. Importance of membrane-bound catechol-O-methyltransferase in L-DOPA metabolism: a pharmacokinetic study in two types of Comt gene modified mice. British Journal of Pharmacology. 158: 1884-94. PMID 19930170 DOI: 10.1111/J.1476-5381.2009.00494.X |
0.701 |
|
| 2009 |
Xu B, Woodroffe A, Rodriguez-Murillo L, Roos JL, van Rensburg EJ, Abecasis GR, Gogos JA, Karayiorgou M. Elucidating the genetic architecture of familial schizophrenia using rare copy number variant and linkage scans. Proceedings of the National Academy of Sciences of the United States of America. 106: 16746-51. PMID 19805367 DOI: 10.1073/Pnas.0908584106 |
0.76 |
|
| 2009 |
Stark KL, Burt RA, Gogos JA, Karayiorgou M. Analysis of prepulse inhibition in mouse lines overexpressing 22q11.2 orthologues. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 12: 983-9. PMID 19519974 DOI: 10.1017/S1461145709000492 |
0.741 |
|
| 2009 |
Tenorio-Laranga J, Männistö PT, Karayiorgou M, Gogos JA, García-Horsman JA. Sex-dependent compensated oxidative stress in the mouse liver upon deletion of catechol O-methyltransferase. Biochemical Pharmacology. 77: 1541-52. PMID 19426692 DOI: 10.1016/J.Bcp.2009.02.004 |
0.696 |
|
| 2009 |
Ng MY, Levinson DF, Faraone SV, Suarez BK, DeLisi LE, Arinami T, Riley B, Paunio T, Pulver AE, Irmansyah, Holmans PA, Escamilla M, Wildenauer DB, Williams NM, Laurent C, ... ... Karayiorgou M, et al. Meta-analysis of 32 genome-wide linkage studies of schizophrenia. Molecular Psychiatry. 14: 774-85. PMID 19349958 DOI: 10.1038/Mp.2008.135 |
0.392 |
|
| 2009 |
Roos JL, Pretorius HW, Karayiorgou M. Clinical characteristics of an Afrikaner founder population recruited for a schizophrenia genetic study. Annals of the New York Academy of Sciences. 1151: 85-101. PMID 19154519 DOI: 10.1111/J.1749-6632.2008.03453.X |
0.447 |
|
| 2008 |
Mukai J, Dhilla A, Drew LJ, Stark KL, Cao L, MacDermott AB, Karayiorgou M, Gogos JA. Palmitoylation-dependent neurodevelopmental deficits in a mouse model of 22q11 microdeletion. Nature Neuroscience. 11: 1302-10. PMID 18836441 DOI: 10.1038/Nn.2204 |
0.817 |
|
| 2008 |
Kambur O, Männistö PT, Viljakka K, Reenilä I, Lemberg K, Kontinen VK, Karayiorgou M, Gogos JA, Kalso E. Stress-induced analgesia and morphine responses are changed in catechol-O-methyltransferase-deficient male mice. Basic & Clinical Pharmacology & Toxicology. 103: 367-73. PMID 18834357 DOI: 10.1111/J.1742-7843.2008.00289.X |
0.684 |
|
| 2008 |
Tammimäki A, Forsberg MM, Karayiorgou M, Gogos JA, Männistö PT. Increase in free choice oral ethanol self-administration in catechol-o-methyltransferase gene-disrupted male mice. Basic & Clinical Pharmacology & Toxicology. 103: 297-304. PMID 18684228 DOI: 10.1111/J.1742-7843.2008.00267.X |
0.684 |
|
| 2008 |
Babovic D, O'Tuathaigh CM, O'Connor AM, O'Sullivan GJ, Tighe O, Croke DT, Karayiorgou M, Gogos JA, Cotter D, Waddington JL. Phenotypic characterization of cognition and social behavior in mice with heterozygous versus homozygous deletion of catechol-O-methyltransferase. Neuroscience. 155: 1021-9. PMID 18674597 DOI: 10.1016/J.Neuroscience.2008.07.006 |
0.731 |
|
| 2008 |
Xu B, Roos JL, Levy S, van Rensburg EJ, Gogos JA, Karayiorgou M. Strong association of de novo copy number mutations with sporadic schizophrenia. Nature Genetics. 40: 880-5. PMID 18511947 DOI: 10.1038/Ng.162 |
0.766 |
|
| 2008 |
Stark KL, Xu B, Bagchi A, Lai WS, Liu H, Hsu R, Wan X, Pavlidis P, Mills AA, Karayiorgou M, Gogos JA. Altered brain microRNA biogenesis contributes to phenotypic deficits in a 22q11-deletion mouse model. Nature Genetics. 40: 751-60. PMID 18469815 DOI: 10.1038/Ng.138 |
0.742 |
|
| 2008 |
Kvajo M, McKellar H, Arguello PA, Drew LJ, Moore H, MacDermott AB, Karayiorgou M, Gogos JA. A mutation in mouse Disc1 that models a schizophrenia risk allele leads to specific alterations in neuronal architecture and cognition. Proceedings of the National Academy of Sciences of the United States of America. 105: 7076-81. PMID 18458327 DOI: 10.1073/Pnas.0802615105 |
0.83 |
|
| 2008 |
Kvajo M, Dhilla A, Swor DE, Karayiorgou M, Gogos JA. Evidence implicating the candidate schizophrenia/bipolar disorder susceptibility gene G72 in mitochondrial function. Molecular Psychiatry. 13: 685-96. PMID 17684499 DOI: 10.1038/Sj.Mp.4002052 |
0.719 |
|
| 2008 |
Arguello A, Moore H, Karayiorgou M, Gogos J. A MUTATION IN MOUSE DISC1 RESEMBLING A SCHIZOPHRENIA RISK ALLELE LEADS TO IMPAIRMENTS OF HIGHER ORDER COGNITION Schizophrenia Research. 102: 57. DOI: 10.1016/S0920-9964(08)70177-4 |
0.743 |
|
| 2007 |
Seedat F, Roos JL, Pretorius HW, Karayiorgou M, Nel B. Prevalence and clinical characteristics of obsessive-compulsive disorder and obsessive compulsive symptoms in Afrikaner schizophrenia and schizoaffective disorder patients. African Journal of Psychiatry. 10: 219-24. PMID 19588030 DOI: 10.4314/Ajpsy.V10I4.30259 |
0.375 |
|
| 2007 |
Hsu R, Woodroffe A, Lai WS, Cook MN, Mukai J, Dunning JP, Swanson DJ, Roos JL, Abecasis GR, Karayiorgou M, Gogos JA. Nogo Receptor 1 (RTN4R) as a candidate gene for schizophrenia: analysis using human and mouse genetic approaches. Plos One. 2: e1234. PMID 18043741 DOI: 10.1371/Journal.Pone.0001234 |
0.79 |
|
| 2007 |
Yavich L, Forsberg MM, Karayiorgou M, Gogos JA, Männistö PT. Site-specific role of catechol-O-methyltransferase in dopamine overflow within prefrontal cortex and dorsal striatum. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 10196-209. PMID 17881525 DOI: 10.1523/Jneurosci.0665-07.2007 |
0.698 |
|
| 2007 |
Babovic D, O'Tuathaigh CM, O'Sullivan GJ, Clifford JJ, Tighe O, Croke DT, Karayiorgou M, Gogos JA, Cotter D, Waddington JL. Exploratory and habituation phenotype of heterozygous and homozygous COMT knockout mice. Behavioural Brain Research. 183: 236-9. PMID 17707921 DOI: 10.1016/J.Bbr.2007.07.006 |
0.786 |
|
| 2007 |
Francks C, Maegawa S, Laurén J, Abrahams BS, Velayos-Baeza A, Medland SE, Colella S, Groszer M, McAuley EZ, Caffrey TM, Timmusk T, Pruunsild P, Koppel I, Lind PA, Matsumoto-Itaba N, ... ... Karayiorgou M, et al. LRRTM1 on chromosome 2p12 is a maternally suppressed gene that is associated paternally with handedness and schizophrenia. Molecular Psychiatry. 12: 1129-39, 1057. PMID 17667961 DOI: 10.1038/Sj.Mp.4002053 |
0.467 |
|
| 2006 |
Lai WS, Xu B, Westphal KG, Paterlini M, Olivier B, Pavlidis P, Karayiorgou M, Gogos JA. Akt1 deficiency affects neuronal morphology and predisposes to abnormalities in prefrontal cortex functioning. Proceedings of the National Academy of Sciences of the United States of America. 103: 16906-11. PMID 17077150 DOI: 10.1073/Pnas.0604994103 |
0.76 |
|
| 2006 |
Karayiorgou M, Gogos JA. Schizophrenia genetics: uncovering positional candidate genes. European Journal of Human Genetics : Ejhg. 14: 512-9. PMID 16493444 DOI: 10.1038/Sj.Ejhg.5201587 |
0.774 |
|
| 2006 |
Koike H, Arguello PA, Kvajo M, Karayiorgou M, Gogos JA. Disc1 is mutated in the 129S6/SvEv strain and modulates working memory in mice. Proceedings of the National Academy of Sciences of the United States of America. 103: 3693-7. PMID 16484369 DOI: 10.1073/Pnas.0511189103 |
0.766 |
|
| 2006 |
Woodroffe A, Abecasis G, Roos JL, Gogos J, Karayiorgou M. Genome-Wide Linkage Scan and Follow-Up Association Analysis for Schizophrenia in an Afrikaner Founder Population American Journal of Epidemiology. 163: S126-S126. DOI: 10.1093/Aje/163.Suppl_11.S126-D |
0.724 |
|
| 2005 |
Paterlini M, Zakharenko SS, Lai WS, Qin J, Zhang H, Mukai J, Westphal KG, Olivier B, Sulzer D, Pavlidis P, Siegelbaum SA, Karayiorgou M, Gogos JA. Transcriptional and behavioral interaction between 22q11.2 orthologs modulates schizophrenia-related phenotypes in mice. Nature Neuroscience. 8: 1586-94. PMID 16234811 DOI: 10.1038/Nn1562 |
0.788 |
|
| 2005 |
Sobin C, Kiley-Brabeck K, Karayiorgou M. Lower prepulse inhibition in children with the 22q11 deletion syndrome. The American Journal of Psychiatry. 162: 1090-9. PMID 15930057 DOI: 10.1176/Appi.Ajp.162.6.1090 |
0.356 |
|
| 2005 |
Sobin C, Kiley-Brabeck K, Karayiorgou M. Associations between prepulse inhibition and executive visual attention in children with the 22q11 deletion syndrome. Molecular Psychiatry. 10: 553-62. PMID 15520831 DOI: 10.1038/Sj.Mp.4001609 |
0.307 |
|
| 2005 |
Scholtz MC, Janse van Rensburg MS, Roos JL, Pretorius HW, Karayiorgou M, Levin JB. Early non-psychotic deviant behaviour as an endophenotypic marker in bipolar disorder, schizo-affective disorder and schizophrenia South African Psychiatry Review. 8: 153-159. DOI: 10.4314/Ajpsy.V8I4.30198 |
0.393 |
|
| 2004 |
Karayiorgou M, Gogos JA. The molecular genetics of the 22q11-associated schizophrenia. Brain Research. Molecular Brain Research. 132: 95-104. PMID 15582150 DOI: 10.1016/J.Molbrainres.2004.09.029 |
0.792 |
|
| 2004 |
Forsberg MM, Juvonen RO, Helisalmi P, Leppänen J, Gogos JA, Karayiorgou M, Männistö PT. Lack of increased oxidative stress in catechol-O-methyltransferase (COMT)-deficient mice. Naunyn-Schmiedeberg's Archives of Pharmacology. 370: 279-89. PMID 15378229 DOI: 10.1007/S00210-004-0967-9 |
0.694 |
|
| 2004 |
Wiehahn GJ, Bosch GP, du Preez RR, Pretorius HW, Karayiorgou M, Roos JL. Assessment of the frequency of the 22q11 deletion in Afrikaner schizophrenic patients. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 129: 20-2. PMID 15274032 DOI: 10.1002/Ajmg.B.20168 |
0.416 |
|
| 2004 |
Hall D, Gogos JA, Karayiorgou M. The contribution of three strong candidate schizophrenia susceptibility genes in demographically distinct populations. Genes, Brain, and Behavior. 3: 240-8. PMID 15248869 DOI: 10.1111/J.1601-183X.2004.00078.X |
0.743 |
|
| 2004 |
Mukai J, Liu H, Burt RA, Swor DE, Lai WS, Karayiorgou M, Gogos JA. Evidence that the gene encoding ZDHHC8 contributes to the risk of schizophrenia. Nature Genetics. 36: 725-31. PMID 15184899 DOI: 10.1038/Ng1375 |
0.759 |
|
| 2004 |
Emamian ES, Karayiorgou M, Gogos JA. Decreased phosphorylation of NMDA receptor type 1 at serine 897 in brains of patients with Schizophrenia. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 1561-4. PMID 14973229 DOI: 10.1523/Jneurosci.4650-03.2004 |
0.738 |
|
| 2004 |
Abecasis GR, Burt RA, Hall D, Bochum S, Doheny KF, Lundy SL, Torrington M, Roos JL, Gogos JA, Karayiorgou M. Genomewide scan in families with schizophrenia from the founder population of Afrikaners reveals evidence for linkage and uniparental disomy on chromosome 1. American Journal of Human Genetics. 74: 403-17. PMID 14750073 DOI: 10.1086/381713 |
0.77 |
|
| 2004 |
Emamian ES, Hall D, Birnbaum MJ, Karayiorgou M, Gogos JA. Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia. Nature Genetics. 36: 131-7. PMID 14745448 DOI: 10.1038/Ng1296 |
0.765 |
|
| 2004 |
Karayiorgou M, Torrington M, Abecasis GR, Pretorius H, Robertson B, Kaliski S, Lay S, Sobin C, Möller N, Lundy SL, Blundell ML, Gogos JA, Roos JL. Phenotypic characterization and genealogical tracing in an Afrikaner schizophrenia database. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 124: 20-8. PMID 14681908 DOI: 10.1002/Ajmg.B.20090 |
0.726 |
|
| 2004 |
Huotari M, García-Horsman JA, Karayiorgou M, Gogos JA, Männistö PT. D-amphetamine responses in catechol-O-methyltransferase (COMT) disrupted mice. Psychopharmacology. 172: 1-10. PMID 14574438 DOI: 10.1007/S00213-003-1627-3 |
0.699 |
|
| 2004 |
Roos JL, Pretorius HW, Karayiorgou M. Multiple affected Afrikaner families in a schizophrenia genetic study: environmental risk factors in interaction with genotypes: original article African Journal of Psychiatry. 7. DOI: 10.4314/Ajpsy.V7I4.30173 |
0.408 |
|
| 2004 |
Roos JL, Pretorius HW, Karayiorgou M. Multiple affected Afrikaner families in a schizophrenia genetic study: Environmental risk factors in interaction with genotypes South African Psychiatry Review. 7: 10-14. |
0.311 |
|
| 2003 |
Zacharia LC, Gogos JA, Karayiorgou M, Jackson EK, Gillespie DG, Barchiesi F, Dubey RK. Methoxyestradiols mediate the antimitogenic effects of 17beta-estradiol: direct evidence from catechol-O-methyltransferase-knockout mice. Circulation. 108: 2974-8. PMID 14662705 DOI: 10.1161/01.Cir.0000106900.66354.30 |
0.688 |
|
| 2003 |
Helkamaa T, Männistö PT, Rauhala P, Cheng ZJ, Finckenberg P, Huotari M, Gogos JA, Karayiorgou M, Mervaala EM. Resistance to salt-induced hypertension in catechol-O-methyltransferase-gene-disrupted mice. Journal of Hypertension. 21: 2365-74. PMID 14654758 DOI: 10.1097/00004872-200312000-00026 |
0.696 |
|
| 2003 |
Wijsman EM, Rosenthal EA, Hall D, Blundell ML, Sobin C, Heath SC, Williams R, Brownstein MJ, Gogos JA, Karayiorgou M. Genome-wide scan in a large complex pedigree with predominantly male schizophrenics from the island of Kosrae: evidence for linkage to chromosome 2q. Molecular Psychiatry. 8: 695-705, 643. PMID 12874606 DOI: 10.1038/Sj.Mp.4001356 |
0.765 |
|
| 2003 |
Gerber DJ, Hall D, Miyakawa T, Demars S, Gogos JA, Karayiorgou M, Tonegawa S. Evidence for association of schizophrenia with genetic variation in the 8p21.3 gene, PPP3CC, encoding the calcineurin gamma subunit. Proceedings of the National Academy of Sciences of the United States of America. 100: 8993-8. PMID 12851458 DOI: 10.1073/pnas.1432927100 |
0.772 |
|
| 2003 |
Hall D, Dhilla A, Charalambous A, Gogos JA, Karayiorgou M. Sequence variants of the brain-derived neurotrophic factor (BDNF) gene are strongly associated with obsessive-compulsive disorder. American Journal of Human Genetics. 73: 370-6. PMID 12836135 DOI: 10.1086/377003 |
0.71 |
|
| 2003 |
Karayiorgou M, Gogos JA. Genes for schizophrenia. Lancet (London, England). 361: 1828-9; author reply. PMID 12781572 DOI: 10.1016/S0140-6736(03)13432-0 |
0.762 |
|
| 2003 |
Sobin C, Roos JL, Pretorius H, Lundy LS, Karayiorgou M. A comparison study of early non-psychotic deviant behavior in Afrikaner and US patients with schizophrenia or schizoaffective disorder. Psychiatry Research. 117: 113-25. PMID 12606014 DOI: 10.1016/S0165-1781(02)00321-9 |
0.383 |
|
| 2002 |
Liu H, Abecasis GR, Heath SC, Knowles A, Demars S, Chen YJ, Roos JL, Rapoport JL, Gogos JA, Karayiorgou M. Genetic variation in the 22q11 locus and susceptibility to schizophrenia. Proceedings of the National Academy of Sciences of the United States of America. 99: 16859-64. PMID 12477929 DOI: 10.1073/Pnas.232186099 |
0.784 |
|
| 2002 |
Huotari M, Santha M, Lucas LR, Karayiorgou M, Gogos JA, Männistö PT. Effect of dopamine uptake inhibition on brain catecholamine levels and locomotion in catechol-O-methyltransferase-disrupted mice. The Journal of Pharmacology and Experimental Therapeutics. 303: 1309-16. PMID 12438556 DOI: 10.1124/Jpet.102.043042 |
0.708 |
|
| 2002 |
Odlind C, Reenilä I, Männistö PT, Juvonen R, Uhlén S, Gogos JA, Karayiorgou M, Hansell P. Reduced natriuretic response to acute sodium loading in COMT gene deleted mice. Bmc Physiology. 2: 14. PMID 12188925 DOI: 10.1186/1472-6793-2-14 |
0.708 |
|
| 2002 |
Hall D, Wijsman EM, Roos JL, Gogos JA, Karayiorgou M. Extended intermarker linkage disequilibrium in the Afrikaners. Genome Research. 12: 956-61. PMID 12045148 DOI: 10.1101/Gr.136202 |
0.692 |
|
| 2002 |
Liu H, Heath SC, Sobin C, Roos JL, Galke BL, Blundell ML, Lenane M, Robertson B, Wijsman EM, Rapoport JL, Gogos JA, Karayiorgou M. Genetic variation at the 22q11 PRODH2/DGCR6 locus presents an unusual pattern and increases susceptibility to schizophrenia. Proceedings of the National Academy of Sciences of the United States of America. 99: 3717-22. PMID 11891283 DOI: 10.1073/Pnas.042700699 |
0.788 |
|
| 2002 |
Huotari M, Gogos JA, Karayiorgou M, Koponen O, Forsberg M, Raasmaja A, Hyttinen J, Männistö PT. Brain catecholamine metabolism in catechol-O-methyltransferase (COMT)-deficient mice. The European Journal of Neuroscience. 15: 246-56. PMID 11849292 DOI: 10.1046/J.0953-816X.2001.01856.X |
0.724 |
|
| 2001 |
Gogos JA, Karayiorgou M. Model-free vs. model-based linkage analysis: A false dichotomy? American Journal of Medical Genetics - Neuropsychiatric Genetics. 105: 62-64. PMID 11425002 DOI: 10.1002/1096-8628(20010108)105:1<62::Aid-Ajmg1063>3.0.Co;2-C |
0.662 |
|
| 2001 |
Gogos JA, Karayiorgou M. "Targeting" schizophrenia in mice. American Journal of Medical Genetics. 105: 50-2. PMID 11424997 DOI: 10.1002/1096-8628(20010108)105:1<50::Aid-Ajmg1058>3.0.Co;2-5 |
0.777 |
|
| 2001 |
Sobin C, Blundell ML, Conry A, Weiller F, Gavigan C, Haiman C, Karayiorgou M. Early, non-psychotic deviant behavior in schizophrenia: a possible endophenotypic marker for genetic studies. Psychiatry Research. 101: 101-13. PMID 11286814 DOI: 10.1016/S0165-1781(00)00246-8 |
0.445 |
|
| 2001 |
Karayiorgou M. Genetic aspects of schizophrenia Clinical Neuroscience Research. 1: 158-163. DOI: 10.1016/S1566-2772(00)00015-3 |
0.49 |
|
| 2000 |
Sobin C, Blundell ML, Karayiorgou M. Phenotypic differences in early- and late-onset obsessive-compulsive disorder. Comprehensive Psychiatry. 41: 373-9. PMID 11011834 DOI: 10.1053/Comp.2000.9009 |
0.319 |
|
| 2000 |
Sobin C, Blundell ML, Weiller F, Gavigan C, Haiman C, Karayiorgou M. Evidence of a schizotypy subtype in OCD. Journal of Psychiatric Research. 34: 15-24. PMID 10696829 DOI: 10.1016/S0022-3956(99)00023-0 |
0.412 |
|
| 1999 |
Sobin C, Blundell M, Weiller F, Gavigan C, Haiman C, Karayiorgou M. Phenotypic characteristics of Obsessive-Compulsive Disorder ascertained in adulthood. Journal of Psychiatric Research. 33: 265-73. PMID 10367993 DOI: 10.1016/S0022-3956(98)00061-2 |
0.322 |
|
| 1999 |
Karayiorgou M, Sobin C, Blundell ML, Galke BL, Malinova L, Goldberg P, Ott J, Gogos JA. Family-based association studies support a sexually dimorphic effect of COMT and MAOA on genetic susceptibility to obsessive-compulsive disorder. Biological Psychiatry. 45: 1178-89. PMID 10331110 DOI: 10.1016/S0006-3223(98)00319-9 |
0.729 |
|
| 1999 |
Winick JD, Blundell ML, Galke BL, Salam AA, Leal SM, Karayiorgou M. Homozygosity mapping of the Achromatopsia locus in the Pingelapese. American Journal of Human Genetics. 64: 1679-85. PMID 10330355 DOI: 10.1086/302423 |
0.368 |
|
| 1999 |
Gogos JA, Santha M, Takacs Z, Beck KD, Luine V, Lucas LR, Nadler JV, Karayiorgou M. The gene encoding proline dehydrogenase modulates sensorimotor gating in mice. Nature Genetics. 21: 434-9. PMID 10192398 DOI: 10.1038/7777 |
0.762 |
|
| 1998 |
Gogos JA, Morgan M, Luine V, Santha M, Ogawa S, Pfaff D, Karayiorgou M. Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proceedings of the National Academy of Sciences of the United States of America. 95: 9991-6. PMID 9707588 DOI: 10.1073/Pnas.95.17.9991 |
0.721 |
|
| 1998 |
Karayiorgou M, Gogos JA, Galke BL, Wolyniec PS, Nestadt G, Antonarakis SE, Kazazian HH, Housman DE, Pulver AE. Identification of sequence variants and analysis of the role of the catechol-O-methyl-transferase gene in schizophrenia susceptibility. Biological Psychiatry. 43: 425-31. PMID 9532347 DOI: 10.1016/S0006-3223(97)00202-3 |
0.787 |
|
| 1997 |
Bennett RL, Karayiorgou M, Sobin CA, Norwood TH, Kay MA. Identification of an interstitial deletion in an adult female with schizophrenia, mental retardation, and dysmorphic features: further support for a putative schizophrenia-susceptibility locus at 5q21-23.1. American Journal of Human Genetics. 61: 1450-4. PMID 9399892 DOI: 10.1086/301634 |
0.464 |
|
| 1997 |
Karayiorgou M, Gogos JA. A turning point in schizophrenia genetics. Neuron. 19: 967-79. PMID 9390512 DOI: 10.1016/S0896-6273(00)80390-6 |
0.766 |
|
| 1997 |
Karayiorgou M, Gogos JA. Dissecting the genetic complexity of schizophrenia. Molecular Psychiatry. 2: 211-23. PMID 9152985 DOI: 10.1038/Sj.Mp.4000271 |
0.781 |
|
| 1997 |
Karayiorgou M, Altemus M, Galke BL, Goldman D, Murphy DL, Ott J, Gogos JA. Genotype determining low catechol-O-methyltransferase activity as a risk factor for obsessive-compulsive disorder. Proceedings of the National Academy of Sciences of the United States of America. 94: 4572-5. PMID 9114031 DOI: 10.1073/Pnas.94.9.4572 |
0.726 |
|
| 1997 |
Gogos JA, Lowry W, Karayiorgou M. Selection for retroviral insertions into regulated genes. Journal of Virology. 71: 1644-50. PMID 8995693 DOI: 10.1128/jvi.71.2.1644-1650.1997 |
0.666 |
|
| 1996 |
Karayiorgou M, Gogos JA, Galke BL, Jeffery JA, Nestadt G, Wolyniec PS, Antonarakis SE, Kazazian HH, Housman DE, Driscoll DA, Pulver AE. Genotype and phenotype analysis at the 22q11 schizophrenia susceptibility locus. Cold Spring Harbor Symposia On Quantitative Biology. 61: 835-43. PMID 9246508 DOI: 10.1101/Sqb.1996.061.01.082 |
0.771 |
|
| 1996 |
Pulver AE, Wolyniec PS, Housman D, Kazazian HH, Antonarakis SE, Nestadt G, Lasseter VK, McGrath JA, Dombroski B, Karayiorgou M, Ton C, Blouin JL, Kempf L. The Johns Hopkins University Collaborative Schizophrenia Study: an epidemiologic-genetic approach to test the heterogeneity hypothesis and identify schizophrenia susceptibility genes. Cold Spring Harbor Symposia On Quantitative Biology. 61: 797-814. PMID 9246505 DOI: 10.1101/Sqb.1996.061.01.079 |
0.486 |
|
| 1996 |
Wildenauer DB, Schwab SG, Albus M, Hallmayer J, Lerer B, Maier W, Blackwood D, Muir W, Clair DS, Morris S, Moises HW, Yang L, Kristbjarnarson H, Helgason T, Wiese C, ... ... Karayiorgou M, et al. Additional support for schizophrenia linkage on chromosomes 6 and 8: A multicenter study American Journal of Medical Genetics. 67: 580-594. PMID 8950417 DOI: 10.1002/(Sici)1096-8628(19961122)67:6<580::Aid-Ajmg11>3.0.Co;2-P |
0.362 |
|
| 1996 |
Gogos JA, Karayiorgou M. Sequence-specific and length-dependent interaction of C2H2 zinc fingers and (TA)n microsatellites. Human Genetics. 98: 616-9. PMID 8882885 DOI: 10.1007/S004390050269 |
0.663 |
|
| 1996 |
Stoffel M, Karayiorgou M, Espinosa R, Beau MM. The human mitochondrial citrate transporter gene (SLC20A3) maps to chromosome band 22q11 within a region implicated in DiGeorge syndrome, velo-cardio-facial syndrome and schizophrenia. Human Genetics. 98: 113-5. PMID 8682495 DOI: 10.1007/S004390050169 |
0.386 |
|
| 1996 |
Antonarakis SE, Blouin JL, Curran M, Luebbert H, Kazazian HH, Dombroski B, Housman D, Ton C, Karayiorgou M, Chakravarti A, Wolyniec P, Lasseter VK, Nestadt G, Pulver AE. Linkage and sib-pair analysis reveal a potential schizophrenia susceptibility gene on chromosome 13q32 Psychiatric Genetics. 6: 136. DOI: 10.1097/00041444-199623000-00009 |
0.36 |
|
| 1996 |
Pulver A, Antonarakis S, Blouin J, Ton C, Housman D, Karayiorgou M, Wolyniec P, Lasseter V, Nestadt G, DeMarchi N, Loetscher E, Luebbert H, Kazazian H, Williams S. Schizophrenia loci: Data of the JHU collaborative group Biological Psychiatry. 39: 614. DOI: 10.1016/0006-3223(96)84332-0 |
0.429 |
|
| 1995 |
Karayiorgou M, Morris MA, Morrow B, Shprintzen RJ, Goldberg R, Borrow J, Gos A, Nestadt G, Wolyniec PS, Lasseter VK. Schizophrenia susceptibility associated with interstitial deletions of chromosome 22q11. Proceedings of the National Academy of Sciences of the United States of America. 92: 7612-6. PMID 7644464 DOI: 10.1073/Pnas.92.17.7612 |
0.508 |
|
| 1995 |
Lasseter VK, Pulver AE, Wolyniec PS, Nestadt G, Meyers D, Karayiorgou M, Housman D, Antonarakis S, Kazazian H, Kasch L. Follow-up report of potential linkage for schizophrenia on chromosome 22q: Part 3. American Journal of Medical Genetics. 60: 172-3. PMID 7485255 DOI: 10.1002/Ajmg.1320600217 |
0.328 |
|
| 1994 |
Pulver AE, Karayiorgou M, Wolyniec PS, Lasseter VK, Kasch L, Nestadt G, Antonarakis S, Housman D, Kazazian HH, Meyers D. Sequential strategy to identify a susceptibility gene for schizophrenia: report of potential linkage on chromosome 22q12-q13.1: Part 1. American Journal of Medical Genetics. 54: 36-43. PMID 8178837 DOI: 10.1002/Ajmg.1320540108 |
0.405 |
|
| 1994 |
Pulver AE, Karayiorgou M, Lasseter VK, Wolyniec P, Kasch L, Antonarakis S, Housman D, Kazazian HH, Meyers D, Nestadt G. Follow-up of a report of a potential linkage for schizophrenia on chromosome 22q12-q13.1: Part 2. American Journal of Medical Genetics. 54: 44-50. PMID 7909990 DOI: 10.1002/Ajmg.1320540109 |
0.365 |
|
| 1994 |
Karayiorgou M, Kasch L, Lasseter VK, Hwang J, Elango R, Bernardini DJ, Kimberland M, Babb R, Francomano CA, Wolyniec PS. Report from the Maryland Epidemiology Schizophrenia Linkage Study: no evidence for linkage between schizophrenia and a number of candidate and other genomic regions using a complex dominant model. American Journal of Medical Genetics. 54: 345-53. PMID 7726207 DOI: 10.1002/Ajmg.1320540413 |
0.364 |
|
| 1993 |
Pulver A, Karayiorgou M, DeMarchi N, Antonarakis S, Housman D, Kasch L, Kazazian H, Lamacz M, Lasseter V, McGrath J, Meyers D, Nestadt G, Ott J, Ramu E, Wolyniec P, et al. Exclusion of linkage between schizophrenia and some candidate genes Schizophrenia Research. 9: 123. DOI: 10.1016/0920-9964(93)90184-K |
0.378 |
|
| 1990 |
Gogos JA, Karayiorgou M, Aburatani H, Kafatos FC. Detection of single base mismatches of thymine and cytosine residues by potassium permanganate and hydroxylamine in the presence of tetralkylammonium salts. Nucleic Acids Research. 18: 6807-14. PMID 2263445 DOI: 10.1093/nar/18.23.6807 |
0.641 |
|
| Show low-probability matches. |